Xi Lei

Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia.

Exercise does not protect the female heart: an unconvincing conclusion?

Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.

Sildenafil-induced cardioprotection in rabbits.

Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.

Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice.

Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling.

Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice.

Genetic deletion of fas receptors or Fas ligands does not reduce infarct size after acute global ischemia-reperfusion in isolated mouse heart.

Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain.

[Dynamic changes of morphological parameters of tobacco root in field].

Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.

eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts.

Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.

Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta.

The current strategy of repair of tetralogy of Fallot in children and adults.

Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice.

Commentaries on viewpoint: effect of altitude on leptin, does it go up or down?

Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.

Investigation of voltammetric enzyme-linked immunoassay system based on N-heterocyclic substrate of 2,3-diaminopyridine.

The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha.

Investigation on solvation and protonation of meso-tetrakis(p-sulfonatophenyl)porphyrin in imidazolium-based ionic liquids by spectroscopic methods.

Design of one-to-one recognition triple Au nanoparticles DNA probe and its application in the electrochemical DNA biosensor.

A rapid and simple chemiluminescence method for screening levels of inosine and hypoxanthine in non-traumatic chest pain patients.

Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.

Hypoxia inducible factor 1 (HIF-1) and cardioprotection.

Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity.

Photoacoustic imaging based on MEMS mirror scanning.

Early changes in morphology and intraocular pressure by size of clear corneal incision.

Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.

CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.

Type 2 diabetic Obese db/db mice are refractory to myocardial ischemic postconditioning In Vivo: potential role for Hsp20, F(1) -ATPase δ, and Echs1.

Integrated diffuse optical tomography and photoacoustic tomography: phantom validations.

Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.

Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.

Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.